Boosting Chinese Healthcare Service Providers' Utilization of Smoking Cessation Interventions by 'WeChat WeQuit' Program

Smoking Abstinence Clinical Trial

Official title:

Boosting Chinese Healthcare Service Providers' Utilization of Behavioral and Pharmacotherapy Interventions for Cigarette Smoking Cessation by 'WeChat WeQuit' Program

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03556774
• Other study ID #: 2017S094
• Status: Recruiting
• Phase: N/A
• Start date: April 1, 2019
• Est. completion date: August 30, 2021

Study information

• Verified date: August 2020
• Source: Sir Run Run Shaw Hospital
• Contact: Yanhui Liao, MD
• Phone: +8615116225099
• Email: tangliaoyanhui[@]163.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this single-blind, randomized trial, undertaken in China with 8-week interventions and follow-up to 52 weeks, about 2,200 providers will be randomly allocated to the intervention or control group.

Description:

Previous studies have been showed that providing behavioral and pharmacotherapy interventions for cigarette smoking patients was effective but rare among Chinese healthcare service providers. In order to minimize the huge gap between the shortage and demand for smoking cessation training program and smoking cessation service, this 'WeChat WeQuit' smoking cessation training program has been designed to assess whether it will increase Chinese healthcare service providers' utilization of behavioral and pharmacotherapy interventions for cigarette smoking cessation or not.

In this single-blind, randomized trial, about 2200 HSPs will be randomly selected (by randomizeR, https://CRAN.R-project.org/package=randomizeR) to 8-week intervention (behavioral and pharmacotherapy interventions for cigarette smoking patients to help them quit smoking) group or control group that only communicates without any standard smoking cessation practices related messages, and follow-up to 52 weeks. The trial will be carried out in into two phases, the first phase is the pilot study (n=200, 8-week intervention and follow-up to 16 weeks) and the second is the main study (n=2000, 8-week intervention and follow-up to 52 weeks). It is hypothesized that 'WeChat WeQuit' training program will improve Chinese HSPs' utilization of behavioral and pharmacotherapy interventions for cigarette smoking cessation and increase quit rate for smoking patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2200
• Est. completion date: August 30, 2021
• Est. primary completion date: August 30, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

1. Chinese-speaking healthcare service providers

2. Know how to use WeChat

3. Use WeChat on a daily basis

4. Willing to provide informed consent to participate in the study -

Exclusion Criteria:

1. Non-Chinese speakers

2. Not healthcare service providers

3. Do not use WeChat

4. Unwilling to participate in the study -

Related Conditions & MeSH terms

• Smoking Abstinence
• Smoking Cessation Intervention

Intervention

Behavioral:
• 'WeChat WeQuit' smoking cessation training program
Providing 'WeChat WeQuit' smoking cessation training program for healthcare service providers (HSPs) and assessing their utilization of behavioral and pharmacotherapy interventions for cigarette smoking cessation.

Locations

Country	Name	City	State
China	Yanhui Liao	Hangzhou	Zhejiang

Sponsors (2)

Lead Sponsor	Collaborator
Sir Run Run Shaw Hospital	Pfizer

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The effectiveness of 'WeChat WeQuit' training program.	The utilization rate (i.e. rate=smokers treated divided by smokers seen) of behavioral and pharmacotherapy interventions by HSP for smoking patients from 8 to 52-week.	52 weeks
Secondary	Prevalence of smoking abstinence	The proportion of smoking patients with 7-day point prevalence smoking abstinence (not even a puff of smoke, for the last 7 days) at 4, 8, 12, 16, 20 and continuously abstinence assessed at 24-weeks follow-up.	24 weeks